Search
for
Sort by
Research 121–150 of 423
- Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- The effects of common house fly (Musca domestica) larvaederived substances on wound healing in mouse model
- Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report
- Pharmacological Treatment of Alopecia
- Androgen replacement therapy in women
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Drug Repurposing Patent Applications July–September 2025
- Clinical-Exome Sequencing Unveils the Genetic Landscape of Polycystic Ovarian Syndrome (PCOS) Focusing on Lean and Obese Phenotypes: Implications for Cost-Effective Diagnosis and Personalized Treatment
- Study on Changes of 19 Steroids in Plasma From 9 Diagnosed Patients With P450 Oxidoreductase Deficiency
- Systemic Corticosteroids in Vitiligo
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- The Role of Cytochrome P-450 in Dermatology
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Corticosteroids for the treatment of Duchenne muscular dystrophy
- Update on the dermatologic use of systemic glucocorticosteroids
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Hormone therapy in acne
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- Geriatric Dermatologic Therapy
- Jenis-jenis Progestin dalam Preparat Kontrasepsi
- Sex hormones and related compounds, including hormonal contraceptives